Pulsed radiation may offer safer retreatment for brain tumors

NCT ID NCT05393258

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This pilot study tested a new way to deliver radiation therapy to people with recurrent IDH-mutant gliomas who had already received radiation to the brain. Instead of giving one large dose, the radiation was given in many small, timed pulses to reduce side effects. The study included 13 participants and focused on safety and symptom burden.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
temporally-modulated pulsed radiation therapy (TMPRT)
What this could lead to
If successful, this radiation technique could offer a safer way to retreat recurrent brain tumors, reducing side effects and improving quality of life for patients who have already had radiation.
What could go wrong
This is a very small pilot study with only 13 participants, so results may not apply to everyone. The main goal was safety, not effectiveness, and it is too early to know if this approach works better than standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTROCYTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Washington University School of Medicine

    St Louis, Missouri, 63110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.